Iron Oxide Nanoparticle-Based Hyperthermia as a Treatment Option in Various Gastrointestinal Malignancies
Abstract
:1. Introduction
2. Materials and Methods
3. Findings
3.1. Esophageal Cancer
3.1.1. Esophageal Cancer: MFH
3.1.2. Esophageal Cancer: PTT
3.2. Gastric Cancer
Gastric Cancer: MFH
3.3. Colorectal Cancer
3.3.1. Colorectal Cancer: MFH
3.3.2. Colorectal Cancer: PTT
3.4. Colorectal Liver Metastasis
3.4.1. Colorectal Liver Metastasis: MFH
3.4.2. Colorectal Liver Metastasis: PTT
3.5. Primary Liver Cancer
3.5.1. Hepatocellular Carcinoma
Hepatocellular Carcinoma: MFH
Hepatocellular Carcinoma: PTT
3.5.2. Cholangiocellular Adenocarcinoma
3.6. Pancreatic Cancer
3.6.1. Pancreatic Cancer: MFH
- (1)
- Investigations on MFH monotherapy (Pancreatic Cancer: MFH Monotherapy).
- (2)
- Investigations on the combination of MFH with additional therapeutic strategies in dual-therapy approaches (Pancreatic Cancer: MFH in Dual Therapy Approaches).
Pancreatic Cancer: MFH Monotherapy
Pancreatic Cancer: MFH in Dual Therapy Approaches
3.6.2. Pancreatic Cancer: PTT
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Commission Européenne. European Technology Platform on Nanomedicine: Nanotechnology for Health: Vision Paper and Basis for a Strategic Research Agenda for Nanomedicine; Office for official publications of the European Communities: Luxembourg, 2005; ISBN 9789289495998. [Google Scholar]
- Russell, R.; Cresanti, R.; Boehm, J.; Carim, A.; Teague, C.; Merzbacher, C.; Holdridge, G. The National Nanotechnology Initiative: Research and Development Leading to a Revolution in Technology and Industry. Supplement to the President’s FY 2008 Budget; Executive Office of the President, National Science and Technology Council: Washington, DC, USA, 2007.
- Ding, N.; Sano, K.; Kanazaki, K.; Ohashi, M.; Deguchi, J.; Kanada, Y.; Ono, M.; Saji, H. In Vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody. Mol. Imaging Biol. 2016, 18, 870–876. [Google Scholar] [CrossRef] [PubMed]
- Lu, C.-Y.; Ji, J.-S.; Zhu, X.-L.; Tang, P.-F.; Zhang, Q.; Zhang, N.-N.; Wang, Z.-H.; Wang, X.-J.; Chen, W.-Q.; Hu, J.-B.; et al. T2-Weighted Magnetic Resonance Imaging of Hepatic Tumor Guided by SPIO-Loaded Nanostructured Lipid Carriers and Ferritin Reporter Genes. ACS Appl. Mater. Interfaces 2017, 9, 35548–35561. [Google Scholar] [CrossRef]
- Zhao, H.; Richardson, R.; Talebloo, N.; Mukherjee, P.; Wang, P.; Moore, A. uMUC1-Targeting Magnetic Resonance Imaging of Therapeutic Response in an Orthotropic Mouse Model of Colon Cancer. Mol. Imaging Biol. 2019, 21, 852–860. [Google Scholar] [CrossRef]
- Wang, G.; Gao, S.; Tian, R.; Miller-Kleinhenz, J.; Qin, Z.; Liu, T.; Li, L.; Zhang, F.; Ma, Q.; Zhu, L. Theranostic Hyaluronic Acid-Iron Micellar Nanoparticles for Magnetic-Field-Enhanced in vivo Cancer Chemotherapy. ChemMedChem 2018, 13, 78–86. [Google Scholar] [CrossRef] [PubMed]
- Jordan, A.; Scholz, R.; Maier-Hauff, K.; Johannsen, M.; Wust, P.; Nadobny, J.; Schirra, H.; Schmidt, H.; Deger, S.; Loening, S.; et al. Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia. J. Magn. Magn. Mater. 2001, 225, 118–126. [Google Scholar] [CrossRef] [Green Version]
- Lee, N.; Hyeon, T. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. Chem. Soc. Rev. 2012, 41, 2575–2589. [Google Scholar] [CrossRef]
- Sun, J.; Kim, D.-H.; Guo, Y.; Teng, Z.; Li, Y.; Zheng, L.; Zhang, Z.; Larson, A.C.; Lu, G. A c(RGDfE) conjugated multi-functional nanomedicine delivery system for targeted pancreatic cancer therapy. J. Mater. Chem. B 2015, 3, 1049–1058. [Google Scholar] [CrossRef]
- Shen, J.-M.; Li, X.-X.; Fan, L.-L.; Zhou, X.; Han, J.-M.; Jia, M.-K.; Wu, L.-F.; Zhang, X.-X.; Chen, J. Heterogeneous dimer peptide-conjugated polylysine dendrimer-Fe3O4 composite as a novel nanoscale molecular probe for early diagnosis and therapy in hepatocellular carcinoma. Int. J. Nanomed. 2017, 12, 1183–1200. [Google Scholar] [CrossRef] [Green Version]
- Li, Y.; Chen, Y.; Li, J.; Zhang, Z.; Huang, C.; Lian, G.; Yang, K.; Chen, S.; Lin, Y.; Wang, L.; et al. Co-delivery of microRNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy. Cancer Sci. 2017, 108, 1493–1503. [Google Scholar] [CrossRef]
- Park, W.; Gordon, A.C.; Cho, S.; Huang, X.; Harris, K.R.; Larson, A.C.; Kim, D.-H. Immunomodulatory Magnetic Microspheres for Augmenting Tumor-Specific Infiltration of Natural Killer (NK) Cells. ACS Appl. Mater. Interfaces 2017, 9, 13819–13824. [Google Scholar] [CrossRef] [Green Version]
- Soenen, S.J.H.; Himmelreich, U.; Nuytten, N.; de Cuyper, M. Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling. Biomaterials 2011, 32, 195–205. [Google Scholar] [CrossRef] [PubMed]
- Thorek, D.L.J.; Chen, A.K.; Czupryna, J.; Tsourkas, A. Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann. Biomed. Eng. 2006, 34, 23–38. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cole, A.J.; Yang, V.C.; David, A.E. Cancer theranostics: The rise of targeted magnetic nanoparticles. Trends Biotechnol. 2011, 29, 323–332. [Google Scholar] [CrossRef] [Green Version]
- Mok, H.; Zhang, M. Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeutics. Expert Opin. Drug Deliv. 2013, 10, 73–87. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Brus, C.; Saif, M.W. Second line therapy for advanced pancreatic adenocarcinoma: Where are we and where are we going? Highlights from the “2010 ASCO Annual Meeting”. Chicago, IL, USA, 4–8 June, 2010. JOP 2010, 11, 321–323. [Google Scholar] [PubMed]
- Stathis, A.; Moore, M.J. Advanced pancreatic carcinoma: Current treatment and future challenges. Nat. Rev. Clin. Oncol. 2010, 7, 163–172. [Google Scholar] [CrossRef]
- Melamed, J.R.; Edelstein, R.S.; Day, E.S. Elucidating the fundamental mechanisms of cell death triggered by photothermal therapy. ACS Nano 2015, 9, 6–11. [Google Scholar] [CrossRef] [PubMed]
- Gellci, K.; Mehrmohammadi, M. Photothermal Therapy. In Encyclopedia of Cancer; Schwab, M., Ed.; Springer: Berlin/Heidelberg, Germany, 2014; pp. 1–5. ISBN 978-3-642-27841-9. [Google Scholar]
- Gilchrist, R.K.; Shorey, W.D.; Hanselman, R.C.; Depeyster, F.A.; Yang, J.; Medal, R. Effects of electromagnetic heating on internal viscera: A preliminary to the treatment of human tumors. Ann. Surg. 1965, 161, 890–896. [Google Scholar] [CrossRef]
- Wang, Y.X.; Hussain, S.M.; Krestin, G.P. Superparamagnetic iron oxide contrast agents: Physicochemical characteristics and applications in MR imaging. Eur. Radiol. 2001, 11, 2319–2331. [Google Scholar] [CrossRef] [Green Version]
- Hergt, R.; Dutz, S.; Müller, R.; Zeisberger, M. Magnetic particle hyperthermia: Nanoparticle magnetism and materials development for cancer therapy. J. Magn. Magn. Mater. 2006, 18, S2919–S2934. [Google Scholar] [CrossRef]
- Magro, M.; Vianello, F. Bare Iron Oxide Nanoparticles: Surface Tunability for Biomedical, Sensing and Environmental Applications. Nanomaterials 2019, 9, 1608. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kikumori, T.; Kobayashi, T.; Sawaki, M.; Imai, T. Anti-cancer effect of hyperthermia on breast cancer by magnetite nanoparticle-loaded anti-HER2 immunoliposomes. Breast Cancer Res. Treat. 2009, 113, 435–441. [Google Scholar] [CrossRef]
- Alphandéry, E.; Faure, S.; Seksek, O.; Guyot, F.; Chebbi, I. Chains of magnetosomes extracted from AMB-1 magnetotactic bacteria for application in alternative magnetic field cancer therapy. ACS Nano 2011, 5, 6279–6296. [Google Scholar] [CrossRef] [PubMed]
- Etemadi, H.; Plieger, P.G. Magnetic Fluid Hyperthermia Based on Magnetic Nanoparticles: Physical Characteristics, Historical Perspective, Clinical Trials, Technological Challenges, and Recent Advances. Adv. Therap. 2020, 3, 2000061. [Google Scholar] [CrossRef]
- Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021, 71, 209–249. [Google Scholar] [CrossRef] [PubMed]
- Roeth, A.A.; Slabu, I.; Baumann, M.; Alizai, P.H.; Schmeding, M.; Guentherodt, G.; Schmitz-Rode, T.; Neumann, U.P. Establishment of a biophysical model to optimize endoscopic targeting of magnetic nanoparticles for cancer treatment. Int. J. Nanomed. 2017, 12, 5933–5940. [Google Scholar] [CrossRef] [Green Version]
- Chu, M.; Shao, Y.; Peng, J.; Dai, X.; Li, H.; Wu, Q.; Shi, D. Near-infrared laser light mediated cancer therapy by photothermal effect of Fe3O4 magnetic nanoparticles. Biomaterials 2013, 34, 4078–4088. [Google Scholar] [CrossRef]
- Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018, 68, 394–424. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yoshida, M.; Watanabe, Y.; Sato, M.; Maehara, T.; Aono, H.; Naohara, T.; Hirazawa, H.; Horiuchi, A.; Yukumi, S.; Sato, K.; et al. Feasibility of chemohyperthermia with docetaxel-embedded magnetoliposomes as minimally invasive local treatment for cancer. Int. J. Cancer 2010, 126, 1955–1965. [Google Scholar] [CrossRef]
- Yoshida, M.; Sato, M.; Yamamoto, Y.; Maehara, T.; Naohara, T.; Aono, H.; Sugishita, H.; Sato, K.; Watanabe, Y. Tumor local chemohyperthermia using docetaxel-embedded magnetoliposomes: Interaction of chemotherapy and hyperthermia. J. Gastroenterol. Hepatol. 2012, 27, 406–411. [Google Scholar] [CrossRef]
- Alison, M.R.; Sarraf, C.E. Apoptosis: Regulation and relevance to toxicology. Hum. Exp. Toxicol. 1995, 14, 234–247. [Google Scholar] [CrossRef] [PubMed]
- Ruan, J.; Ji, J.; Song, H.; Qian, Q.; Wang, K.; Wang, C.; Cui, D. Fluorescent magnetic nanoparticle-labeled mesenchymal stem cells for targeted imaging and hyperthermia therapy of in vivo gastric cancer. Nanoscale Res. Lett. 2012, 7, 309. [Google Scholar] [CrossRef] [Green Version]
- Siegel, R.L.; Miller, K.D.; Goding Sauer, A.; Fedewa, S.A.; Butterly, L.F.; Anderson, J.C.; Cercek, A.; Smith, R.A.; Jemal, A. Colorectal cancer statistics, 2020. CA Cancer J. Clin. 2020, 70, 145–164. [Google Scholar] [CrossRef] [Green Version]
- Rodríguez-Luccioni, H.L.; Latorre-Esteves, M.; Méndez-Vega, J.; Soto, O.; Rodríguez, A.R.; Rinaldi, C.; Torres-Lugo, M. Enhanced reduction in cell viability by hyperthermia induced by magnetic nanoparticles. Int. J. Nanomed. 2011, 6, 373–380. [Google Scholar] [CrossRef] [Green Version]
- Hardiansyah, A.; Huang, L.-Y.; Yang, M.-C.; Liu, T.-Y.; Tsai, S.-C.; Yang, C.-Y.; Kuo, C.-Y.; Chan, T.-Y.; Zou, H.-M.; Lian, W.-N.; et al. Magnetic liposomes for colorectal cancer cells therapy by high-frequency magnetic field treatment. Nanoscale Res. Lett. 2014, 9, 497. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dabaghi, M.; Quaas, R.; Hilger, I. The Treatment of Heterotopic Human Colon Xenograft Tumors in Mice with 5-Fluorouracil Attached to Magnetic Nanoparticles in Combination with Magnetic Hyperthermia Is More Efficient than Either Therapy Alone. Cancers 2020, 12, 2562. [Google Scholar] [CrossRef] [PubMed]
- Kirui, D.K.; Rey, D.A.; Batt, C.A. Gold hybrid nanoparticles for targeted phototherapy and cancer imaging. Nanotechnology 2010, 21, 105105. [Google Scholar] [CrossRef]
- Kirui, D.K.; Khalidov, I.; Wang, Y.; Batt, C.A. Targeted near-IR hybrid magnetic nanoparticles for in vivo cancer therapy and imaging. Nanomedicine 2013, 9, 702–711. [Google Scholar] [CrossRef]
- Yang, S.-J.; Tseng, S.-Y.; Wang, C.-H.; Young, T.-H.; Chen, K.-C.; Shieh, M.-J. Magnetic nanomedicine for CD133-expressing cancer therapy using locoregional hyperthermia combined with chemotherapy. Nanomedicine 2020, 15, 2543–2561. [Google Scholar] [CrossRef]
- Neumann, U.P.; Seehofer, D.; Neuhaus, P. The surgical treatment of hepatic metastases in colorectal carcinoma. Dtsch. Arztebl. Int. 2010, 107, 335–342. [Google Scholar] [CrossRef]
- Arriortua, O.K.; Garaio, E.; La Herrero de Parte, B.; Insausti, M.; Lezama, L.; Plazaola, F.; García, J.A.; Aizpurua, J.M.; Sagartzazu, M.; Irazola, M.; et al. Antitumor magnetic hyperthermia induced by RGD-functionalized Fe3O4 nanoparticles, in an experimental model of colorectal liver metastases. Beilstein J. Nanotechnol. 2016, 7, 1532–1542. [Google Scholar] [CrossRef] [Green Version]
- White, S.B.; Kim, D.-H.; Guo, Y.; Li, W.; Yang, Y.; Chen, J.; Gogineni, V.R.; Larson, A.C. Biofunctionalized Hybrid Magnetic Gold Nanoparticles as Catalysts for Photothermal Ablation of Colorectal Liver Metastases. Radiology 2017, 285, 809–819. [Google Scholar] [CrossRef] [PubMed]
- Mittal, S.; Sada, Y.H.; El-Serag, H.B.; Kanwal, F.; Duan, Z.; Temple, S.; May, S.B.; Kramer, J.R.; Richardson, P.A.; Davila, J.A. Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population. Clin. Gastroenterol. Hepatol. 2015, 13, 594–601.e1. [Google Scholar] [CrossRef] [Green Version]
- Marrero, J.A.; Fontana, R.J.; Su, G.L.; Conjeevaram, H.S.; Emick, D.M.; Lok, A.S. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002, 36, 1349–1354. [Google Scholar] [CrossRef] [PubMed]
- Calle, E.E.; Rodriguez, C.; Walker-Thurmond, K.; Thun, M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 2003, 348, 1625–1638. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Welzel, T.M.; Graubard, B.I.; El-Serag, H.B.; Shaib, Y.H.; Hsing, A.W.; Davila, J.A.; McGlynn, K.A. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based case-control study. Clin. Gastroenterol. Hepatol. 2007, 5, 1221–1228. [Google Scholar] [CrossRef] [Green Version]
- Liao, S.-H.; Liu, C.-H.; Bastakoti, B.P.; Suzuki, N.; Chang, Y.; Yamauchi, Y.; Lin, F.-H.; Wu, K.C.-W. Functionalized magnetic iron oxide/alginate core-shell nanoparticles for targeting hyperthermia. Int. J. Nanomed. 2015, 10, 3315–3327. [Google Scholar] [CrossRef] [Green Version]
- Attaluri, A.; Seshadri, M.; Mirpour, S.; Wabler, M.; Marinho, T.; Furqan, M.; Zhou, H.; de Paoli, S.; Gruettner, C.; Gilson, W.; et al. Image-guided thermal therapy with a dual-contrast magnetic nanoparticle formulation: A feasibility study. Int. J. Hyperth. 2016, 32, 543–557. [Google Scholar] [CrossRef] [Green Version]
- Yang, R.; An, L.Y.; Miao, Q.F.; Li, F.M.; Han, Y.; Wang, H.X.; Liu, D.P.; Chen, R.; Tang, S.Q. Effective elimination of liver cancer stem-like cells by CD90 antibody targeted thermosensitive magnetoliposomes. Oncotarget 2016, 7, 35894–35916. [Google Scholar] [CrossRef] [Green Version]
- Zuchini, R.; Tsai, H.-W.; Chen, C.-Y.; Huang, C.-H.; Huang, S.-C.; Lee, G.-B.; Huang, C.-F.; Lin, X.-Z. Electromagnetic thermotherapy using fine needles for hepatoma treatment. Eur. J. Surg. Oncol. 2011, 37, 604–610. [Google Scholar] [CrossRef]
- Wang, S.J.; Lin, W.Y.; Chen, M.N.; Chi, C.S.; Chen, J.T.; Ho, W.L.; Hsieh, B.T.; Shen, L.H.; Tsai, Z.T.; Ting, G.; et al. Intratumoral injection of rhenium-188 microspheres into an animal model of hepatoma. J. Nucl. Med. 1998, 39, 1752–1757. [Google Scholar]
- Jeon, M.J.; Ahn, C.-H.; Kim, H.; Chung, I.J.; Jung, S.; Kim, Y.-H.; Youn, H.; Chung, J.W.; Kim, Y.I. The intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthermia combined with pharmacotherapy in a hepatocellular carcinoma model. J. Exp. Clin. Cancer Res. 2014, 33, 57. [Google Scholar] [CrossRef] [PubMed]
- Purushotham, S.; Chang, P.E.J.; Rumpel, H.; Kee, I.H.C.; Ng, R.T.H.; Chow, P.K.H.; Tan, C.K.; Ramanujan, R.V. Thermoresponsive core-shell magnetic nanoparticles for combined modalities of cancer therapy. Nanotechnology 2009, 20, 305101. [Google Scholar] [CrossRef]
- Wang, Z.; Chang, Z.; Lu, M.; Shao, D.; Yue, J.; Yang, D.; Zheng, X.; Li, M.; He, K.; Zhang, M.; et al. Shape-controlled magnetic mesoporous silica nanoparticles for magnetically-mediated suicide gene therapy of hepatocellular carcinoma. Biomaterials 2018, 154, 147–157. [Google Scholar] [CrossRef] [PubMed]
- Chan, M.-H.; Lu, C.-N.; Chung, Y.-L.; Chang, Y.-C.; Li, C.-H.; Chen, C.-L.; Wei, D.-H.; Hsiao, M. Magnetically guided theranostics: Montmorillonite-based iron/platinum nanoparticles for enhancing in situ MRI contrast and hepatocellular carcinoma treatment. J. Nanobiotechnology 2021, 19, 308. [Google Scholar] [CrossRef] [PubMed]
- Li, Z.; Zeng, Y.; Zhang, D.; Wu, M.; Wu, L.; Huang, A.; Yang, H.; Liu, X.; Liu, J. Glypican-3 antibody functionalized Prussian blue nanoparticles for targeted MR imaging and photothermal therapy of hepatocellular carcinoma. J. Mater. Chem. B 2014, 2, 3686–3696. [Google Scholar] [CrossRef] [PubMed]
- Liu, X.; Lin, X.; Wu, M.; Lin, R.; Li, B.; Liu, J. SPION@Cu2-xS nanoclusters for highly sensitive MRI and targeted photothermal therapy of hepatocellular carcinoma. J. Mater. Chem. B 2016, 4, 4119–4129. [Google Scholar] [CrossRef] [PubMed]
- Li, Q.; Chen, K.; Huang, W.; Ma, H.; Zhao, X.; Zhang, J.; Zhang, Y.; Fang, C.; Nie, L. Minimally invasive photothermal ablation assisted by laparoscopy as an effective preoperative neoadjuvant treatment for orthotopic hepatocellular carcinoma. Cancer Lett. 2021, 496, 169–178. [Google Scholar] [CrossRef]
- Liu, F.; Li, X.; Li, Y.; Qi, Y.; Yuan, H.; He, J.; Li, W.; Zhou, M. Designing pH-triggered drug release iron oxide nanocomposites for MRI-guided photothermal-chemoembolization therapy of liver orthotopic cancer. Biomater. Sci. 2019, 7, 1842–1851. [Google Scholar] [CrossRef] [PubMed]
- Yuan, H.; Li, X.; Tang, J.; Zhou, M.; Liu, F. Local application of doxorubicin- loaded Iron oxid nanoparticles and the vascular disrupting agent via the hepatic artery: Chemoembolization-photothermal ablation treatment of hepatocellular carcinoma in rats. Cancer Imaging 2019, 19, 71. [Google Scholar] [CrossRef]
- Huang, D.; Dai, H.; Tang, K.; Chen, B.; Zhu, H.; Chen, D.; Li, N.; Wang, Y.; Liu, C.; Huang, Y.; et al. A versatile UCST-type composite microsphere for image-guided chemoembolization and photothermal therapy against liver cancer. Nanoscale 2020, 12, 20002–20015. [Google Scholar] [CrossRef]
- Shu, G.; Chen, M.; Song, J.; Xu, X.; Lu, C.; Du, Y.; Xu, M.; Zhao, Z.; Zhu, M.; Fan, K.; et al. Sialic acid-engineered mesoporous polydopamine nanoparticles loaded with SPIO and Fe3+ as a novel theranostic agent for T1/T2 dual-mode MRI-guided combined chemo-photothermal treatment of hepatic cancer. Bioact. Mater. 2021, 6, 1423–1435. [Google Scholar] [CrossRef] [PubMed]
- Nicolás-Boluda, A.; Vaquero, J.; Laurent, G.; Renault, G.; Bazzi, R.; Donnadieu, E.; Roux, S.; Fouassier, L.; Gazeau, F. Photothermal Depletion of Cancer-Associated Fibroblasts Normalizes Tumor Stiffness in Desmoplastic Cholangiocarcinoma. ACS Nano 2020, 14, 5738–5753. [Google Scholar] [CrossRef] [PubMed]
- Mues, B.; Bauer, B.; Ortega, J.; Buhl, E.M.; Teller, H.; Gries, T.; Schmitz-Rode, T.; Slabu, I. Assessing hyperthermia performance of hybrid textile filaments: The impact of different heating agents. J. Magn. Magn. Mater. 2021, 519, 167486. [Google Scholar] [CrossRef]
- Mues, B.; Bauer, B.; Roeth, A.A.; Ortega, J.; Buhl, E.M.; Radon, P.; Wiekhorst, F.; Gries, T.; Schmitz-Rode, T.; Slabu, I. Nanomagnetic Actuation of Hybrid Stents for Hyperthermia Treatment of Hollow Organ Tumors. Nanomaterials 2021, 11, 618. [Google Scholar] [CrossRef] [PubMed]
- Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer Statistics, 2017. CA Cancer J. Clin. 2017, 67, 7–30. [Google Scholar] [CrossRef] [Green Version]
- Cress, R.D.; Yin, D.; Clarke, L.; Bold, R.; Holly, E.A. Survival among patients with adenocarcinoma of the pancreas: A population-based study (United States). Cancer Causes Control 2006, 17, 403–409. [Google Scholar] [CrossRef]
- Engelmann, U.M.; Roeth, A.A.; Eberbeck, D.; Buhl, E.M.; Neumann, U.P.; Schmitz-Rode, T.; Slabu, I. Combining Bulk Temperature and Nanoheating Enables Advanced Magnetic Fluid Hyperthermia Efficacy on Pancreatic Tumor Cells. Sci. Rep. 2018, 8, 13210. [Google Scholar] [CrossRef] [PubMed]
- Ludwig, R.; Teran, F.J.; Teichgraeber, U.; Hilger, I. Nanoparticle-based hyperthermia distinctly impacts production of ROS, expression of Ki-67, TOP2A, and TPX2, and induction of apoptosis in pancreatic cancer. Int. J. Nanomed. 2017, 12, 1009–1018. [Google Scholar] [CrossRef] [Green Version]
- Slabu, I.; Roeth, A.A.; Engelmann, U.M.; Wiekhorst, F.; Buhl, E.M.; Neumann, U.P.; Schmitz-Rode, T. Modeling of magnetoliposome uptake in human pancreatic tumor cells in vitro. Nanotechnology 2019, 30, 184004. [Google Scholar] [CrossRef]
- Attaluri, A.; Kandala, S.K.; Zhou, H.; Wabler, M.; DeWeese, T.L.; Ivkov, R. Magnetic nanoparticle hyperthermia for treating locally advanced unresectable and borderline resectable pancreatic cancers: The role of tumor size and eddy-current heating. Int. J. Hyperth. 2020, 37, 108–119. [Google Scholar] [CrossRef]
- Basel, M.T.; Balivada, S.; Wang, H.; Shrestha, T.B.; Seo, G.M.; Pyle, M.; Abayaweera, G.; Dani, R.; Koper, O.B.; Tamura, M.; et al. Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model. Int. J. Nanomed. 2012, 7, 297–306. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kossatz, S.; Ludwig, R.; Dähring, H.; Ettelt, V.; Rimkus, G.; Marciello, M.; Salas, G.; Patel, V.; Teran, F.J.; Hilger, I. High therapeutic efficiency of magnetic hyperthermia in xenograft models achieved with moderate temperature dosages in the tumor area. Pharm. Res. 2014, 31, 3274–3288. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dong, J.; Zink, J.I. Taking the temperature of the interiors of magnetically heated nanoparticles. ACS Nano 2014, 8, 5199–5207. [Google Scholar] [CrossRef]
- Palzer, J.; Mues, B.; Goerg, R.; Aberle, M.; Rensen, S.S.; Olde Damink, S.W.M.; Vaes, R.D.W.; Cramer, T.; Schmitz-Rode, T.; Neumann, U.P.; et al. Magnetic Fluid Hyperthermia as Treatment Option for Pancreatic Cancer Cells and Pancreatic Cancer Organoids. Int. J. Nanomed. 2021, 16, 2965–2981. [Google Scholar] [CrossRef]
- Piehler, S.; Wucherpfennig, L.; Tansi, F.L.; Berndt, A.; Quaas, R.; Teichgraeber, U.; Hilger, I. Hyperthermia affects collagen fiber architecture and induces apoptosis in pancreatic and fibroblast tumor hetero-spheroids in vitro. Nanomedicine 2020, 28, 102183. [Google Scholar] [CrossRef]
- Brero, F.; Albino, M.; Antoccia, A.; Arosio, P.; Avolio, M.; Berardinelli, F.; Bettega, D.; Calzolari, P.; Ciocca, M.; Corti, M.; et al. Hadron Therapy, Magnetic Nanoparticles and Hyperthermia: A Promising Combined Tool for Pancreatic Cancer Treatment. Nanomaterials 2020, 10, 1919. [Google Scholar] [CrossRef] [PubMed]
- Jaidev, L.R.; Chellappan, D.R.; Bhavsar, D.V.; Ranganathan, R.; Sivanantham, B.; Subramanian, A.; Sharma, U.; Jagannathan, N.R.; Krishnan, U.M.; Sethuraman, S. Multi-functional nanoparticles as theranostic agents for the treatment & imaging of pancreatic cancer. Acta Biomater. 2017, 49, 422–433. [Google Scholar] [CrossRef]
- Wang, L.; An, Y.; Yuan, C.; Zhang, H.; Liang, C.; Ding, F.; Gao, Q.; Zhang, D. GEM-loaded magnetic albumin nanospheres modified with cetuximab for simultaneous targeting, magnetic resonance imaging, and double-targeted thermochemotherapy of pancreatic cancer cells. Int. J. Nanomed. 2015, 10, 2507–2519. [Google Scholar] [CrossRef] [Green Version]
- Sanhaji, M.; Göring, J.; Couleaud, P.; Aires, A.; Cortajarena, A.L.; Courty, J.; Prina-Mello, A.; Stapf, M.; Ludwig, R.; Volkov, Y.; et al. The phenotype of target pancreatic cancer cells influences cell death by magnetic hyperthermia with nanoparticles carrying gemicitabine and the pseudo-peptide NucAnt. Nanomedicine 2019, 20, 101983. [Google Scholar] [CrossRef]
- Balasubramanian, S.; Ravindran Girija, A.; Nagaoka, Y.; Fukuda, T.; Iwai, S.; Kizhikkilot, V.; Kato, K.; Maekawa, T.; Dasappan Nair, S. An ‘all in one’ approach for simultaneous chemotherapeutic, photothermal and magnetic hyperthermia mediated by hybrid magnetic nanoparticles. RSC Adv. 2015, 5, 25066–25078. [Google Scholar] [CrossRef]
- Guo, Y.; Zhang, Z.; Kim, D.-H.; Li, W.; Nicolai, J.; Procissi, D.; Huan, Y.; Han, G.; Omary, R.A.; Larson, A.C. Photothermal ablation of pancreatic cancer cells with hybrid iron-oxide core gold-shell nanoparticles. Int. J. Nanomed. 2013, 8, 3437–3446. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wang, S.; Zhang, Q.; Luo, X.F.; Li, J.; He, H.; Yang, F.; Di, Y.; Jin, C.; Jiang, X.G.; Shen, S.; et al. Magnetic graphene-based nanotheranostic agent for dual-modality mapping guided photothermal therapy in regional lymph nodal metastasis of pancreatic cancer. Biomaterials 2014, 35, 9473–9483. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Palzer, J.; Eckstein, L.; Slabu, I.; Reisen, O.; Neumann, U.P.; Roeth, A.A. Iron Oxide Nanoparticle-Based Hyperthermia as a Treatment Option in Various Gastrointestinal Malignancies. Nanomaterials 2021, 11, 3013. https://doi.org/10.3390/nano11113013
Palzer J, Eckstein L, Slabu I, Reisen O, Neumann UP, Roeth AA. Iron Oxide Nanoparticle-Based Hyperthermia as a Treatment Option in Various Gastrointestinal Malignancies. Nanomaterials. 2021; 11(11):3013. https://doi.org/10.3390/nano11113013
Chicago/Turabian StylePalzer, Julian, Lea Eckstein, Ioana Slabu, Oliver Reisen, Ulf P. Neumann, and Anjali A. Roeth. 2021. "Iron Oxide Nanoparticle-Based Hyperthermia as a Treatment Option in Various Gastrointestinal Malignancies" Nanomaterials 11, no. 11: 3013. https://doi.org/10.3390/nano11113013